Researchers map pathways to protective antibodies for an HIV vaccine. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2017 / 03 / 170315143838.htm ...

A recent tour-de-force study by the US researchers describes a comprehensive approach to completely map mutations to the SARS-CoV-2 receptor-binding domain (RBD) that escape antibody binding ...

Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive ...

The phase 2b study lays out a path toward developing monoclonal antibody drugs for passive prevention of HIV. ... Monoclonal Antibodies Prevent HIV in Proof-of-Concept Trial - Medscape - Mar 17, 2021.

Results of the Antibody Mediated Prevention, or AMP, trials released on Jan. 26 are an “important proof of concept” that demonstrated the feasibility of blocking HIV with bimonthly infusions of such ...

RLYB211, a polyclonal anti-HPA-1a antibody, is being evaluated for the prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), a potentially life-threatening rare disease that can ...

The vaccinal antibody concept is currently being applied across Vir's pipeline of potential SARS-CoV-2, chronic hepatitis B virus (HBV), and influenza A product candidates, and will now be used to ...

INDIANAPOLIS, Sept. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced proof of concept data from an interim analysis of the BLAZE-1 clinical trial, showing a reduced rate ...

OncoOne Presents Preclinical Proof of Concept Data for its Next-Generation oxMIF-targeted Monoclonal Antibody ON203 at the AACR Annual Meeting April 08, 2022 01:00 PM Eastern Daylight Time ...

Targeting pituitary adenylate cyclase–activating polypeptide (PACAP) is a new avenue for treating migraine. The efficacy and safety of intravenous Lu AG09222, a humanized monoclonal antibody ...